Leo Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$592K Buy
+3,973
New +$557K 0.13% 148
2026
Q1
$1.26M Sell
9,048
-5,849
-39% -$819K 0.09% 159
2025
Q4
$1.83M Buy
14,897
+3,680
+33% +$447K 0.13% 127
2025
Q3
$1.25M Buy
11,217
+1,897
+20% +$216K 0.16% 114
2025
Q2
$1.03M Buy
9,320
+1,749
+23% +$186K 0.08% 172
2025
Q1
$848K Sell
7,571
-4,134
-35% -$427K 0.12% 138
2024
Q4
$1.08M Sell
11,705
-16,394
-58% -$1.48M 0.1% 146
2024
Q3
$2.36M Buy
28,099
+2,752
+11% +$210K 0.22% 79
2024
Q2
$1.74M Sell
25,347
-5,609
-18% -$374K 0.18% 101
2024
Q1
$2.27M Sell
30,956
-3,218
-9% -$247K 0.23% 77
2023
Q4
$2.74M Buy
+34,174
New +$2.66M 0.28% 61

Other funds holding GILD

Leo Wealth's GILD Position: Q3 2026 in Review

Leo Wealth opened a new position in Gilead Sciences (GILD) in Q3 2026: 3,973 shares worth $592K. The stake represents 0.13% of the portfolio and ranks #148 among its holdings. This is a return to the name: Leo Wealth previously reported a position in GILD as recently as Q1 2026.

Leo Wealth first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.74M in Q4 2023. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Leo Wealth held 3,973 shares of Gilead Sciences worth $592K as of Q3 2026.
  • Gilead Sciences was a new Leo Wealth position in Q3 2026.
  • Gilead Sciences made up 0.13% of Leo Wealth's portfolio in Q3 2026, its #148 holding.
  • Leo Wealth first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Leo Wealth's Gilead Sciences position peaked at $2.74M in Q4 2023.
  • 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Leo Wealth's 13F filing for Q3 2026, filed 26 Oct 2026.